Jerome Adams, MD, MPH
Chairman of the Board Total Diversity Clinical Trial Management
Jerome Adams, MD, MPH
Chairman of the Board Total Diversity Clinical Trial Management
Former Vice Admiral Jerome Adams, MD, MPH is the Chairman of the Board at Total Diversity Clinical Trial Management and Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th U.S. Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic including working with companies to increase diversity in vaccine trials.
Sandy Amaro, MBA
Head of Clinical Trial Diversity
Sandra Amaro, MBA, is currently a Senior Director at Pfizer based in Groton, CT. She leads a group of Clinical Trial Diversity Operation Leads and Site Diversity Strategy Leads, who are accountable for enabling Pfizer’s Clinical Study Teams in the effort to increase equity and inclusion in clinical trials. Within her role Sandra is also responsible for helping elevate the topic of diversity both within Pfizer and externally. In 2021 Sandra was appointed as TransCelerate’s Workstream Lead for their Diversity of Participates in Clinical Trials Workstream.
Sandra has been with Pfizer since May 2004, where she has held different leadership positions within Clinical Development and Operations and Global Clinical Supply.
Sandra received her Bachelor of Science in Business and Leadership from Albertus Magnus College, and her Masters of Business Administration from the University of Rhode Island.
Stacey Bledsoe, MSN
Senior Director- Diversity in Clinical Trials
Stacey Bledsoe RN, MSN has over 19 years’ experience in the pharmaceutical industry across multiple disciplines including Research & Development, Global Health Outcomes, Medical and Six Sigma. She has demonstrated success in Six Sigma methodology, Health Outcomes research, medical information, and the hospital and payer environment. Stacey currently leads the initiatives around increasing diverse representation through partnerships and collaboration for Lilly which allows her to use her passion to move this very important topic forward. Prior to beginning her career at Eli Lilly and company she held a Registered Nurse role on the Level III Newborn Intensive Care Unit at Riley Hospital for Children. Stacey earned her Bachelor and Master of Science in Nursing from Indiana University. Stacey’s goal is to help influence and ensure that all patients have access to clinical research and life changing medications that will ultimately improve their lives.
Theresa Devins, DrPH, MS
Director, Clinical Operations
Theresa Devins has over 20 years of clinical research experience in a variety of therapeutic areas including neurology, cardiovascular, respiratory, and metabolism, with expertise in international and national clinical study leadership. She has extensive expertise in recruitment of diverse populations in clinical trials and has developed trusted external partnerships resulting in a broad scope of experience from many perspectives. Theresa has developed innovative approaches to engaging study site networks and has helped them build processes to expedite study start up and to streamline overall study conduct. She believes that by investing time and effort into building a partnership, both organizations may benefit which ultimately can bring new treatment to patients in need faster while maintaining high quality clinical trials. She works tirelessly to understand the needs patients and their families, and to ensure health equity for all patients.
Theresa has earned a doctorate in Public Health and a graduate degree Clinical Research Administration. In her spare time, she enjoys time with her husband and children, and is currently writing a book for children and adolescents on current, complex social issues.
Brandon Doyle, MBA
Associate Site Alliance Director, World Wide Site Strategy (Global Site Solutions)
Brandon Doyle, MBA, is Associate Director, Site Alliances and SME Global Site Diversity Strategy for Parexel. In this role, Brandon serves as a site solutions consultant to prepare sites for the evolving needs and demands in the clinical research trial industry. Brandon joined the SCRS Diversity Program 3 years ago and represented Parexel as the first CRO to join the initiative. He is guided by the belief that every person should have access to clinical research as a continuum to their health care and that diversity, equity and inclusion is essential for a person’s ability to thrive and prosper. Brandon has 22 years in industry under various roles from study coordinator and program director at the site level and clinical enrolment manager and site management at the CRO level. Brandon brings a unique perspective on patient engagement and recruitment through his MBA Marketing degree from Carlson School of Business.
Diana Foster, PhD
VP, Strategy and Special Projects, SCRS Diversity Awareness Lead
Dr. Foster serves as a consultant to the Society for Clinical Research Sites as the Vice President of Strategy and Special Projects. In her role she is responsible for building relationships with industry that help amplify the voice of the clinical research site.
Diana is a recognized expert in the intricacies of site management and an innovator in the use of strategic marketing and positioning tactics. Diana has designed and facilitated site management and patient recruitment trainings across the globe. While serving as president at DAC Patient Recruitment Services (formerly D. Anderson & Company), Diana led the organization through its evolution as a niche site management organization. Her early tenure as head of an SMO, Rheumatology Research International, also gave her a unique understanding of how sites operate and what they need to reach enrollment goals within targeted timelines.
Over the past two decades, Diana has addressed audiences across five continents, published multiple papers and articles, and written five authoritative industry books including “Global Issues in Patient Recruitment and Retention,” a sequel to “International Patient Recruitment: Regulatory Guidelines, Customs and Practices.” The books have served as teaching tools for colleges and universities, along with her earlier works: “A Guide to Patient Recruitment,” “A Guide to Patient Recruitment and Retention” and “50 Ways to Cope with Arthritis.” In addition, she has been a sought after speaker and given copious of presentations across the world.
Her personal honors include recognition by the Global EXEC Women’s International Council as an International Woman of Influence, being named a finalist for Ernst & Young’s Entrepreneur of the Year Awards, and an induction into the PharmaVOICE “100 Most Inspiring People in the Life-Sciences Industry.” She is among accomplished women around the globe who are changing the way international clinical trials are conducted.
Catherine Gregor, MBA, CCRP, CCRC
Chief Clinical Trial Officer
Catherine Gregor, MBA, CCRP, CCRC is the Chief Clinical Trial Officer at Florence. She has more than 15 years of experience analyzing and implementing change across back-office research operations for finance, clinical operations, regulatory, and health information systems. She has worked in a myriad of community and academic environments. Most recently, she served as the Director of Clinical Research Administration at the Vanderbilt-Ingram Cancer Center.
Justus Harris is a well-being coach, designer, and artist based in Chicago and North Carolina. He is a Stanford Medicine X 2019 ePatient Scholar and a 2018-2019 Kennedy Center Citizen Artist Fellow. At age 14 he was diagnosed with type 1 diabetes, combined his artistic training, patient experiences, and educational skills to found MedSculp in 2016. MedSculp creates patient-education tools for people with diabetes that translate personal medical data from charts and graphs into 3D-printed objects and 2D designs that can be intuitively understood. His work has been featured by the European Commission in Berlin, Livongo, Healthline, The American Diabetes Association, Queer, ILL, + OK, and at TEDx Wake Forest in 2020.
In 2021 Justus is excited to expand MedSculp’s offerings. Out Loud Health is his coaching program to help socially conscious professionals prioritize their wellbeing without compromising their authenticity in order to fulfill and grow their life’s purpose. He is committed to having clients write joy back into their stories.
CEO of Quality Clinical Research & Chief Diversity Officer
Seneca Harrison is the Vice President of Operations and CEO of Quality Clinical Research, an expanding research facility catering to residents of the Midwest for nearly 20 years. Mr. Harrison has served as CEO since 2008 and has since made it his mission to diversify clinical trials and extend research to underrepresented demographics. His entrepreneurial spirit and drive has led him to branch out into local communities, opening and owning four other businesses in the Omaha area.
Mr. Harrison currently sits on the board for The Entrepreneurs’ Organization (EO) Nebraska, a global, peer-to-peer network of more than 14,000 influential business owners with 198 chapters in 61 countries. In 2019 Mr. Harrison was named by Omaha Magazine as one of the faces of Omaha for his leadership, entrepreneurialism and outreach in the Omaha community. His company, Quality Clinical Research, has been named in Gallup’s fastest growing small businesses in Nebraska. He remains a prominent figure in the city of Omaha and continues to give back through his many business ventures.
Mr. Harrison has spent the last 13 years leading the way toward a broader and more inclusive view of clinical research, and now, currently serves as the Chief Diversity Officer for hyperCore international. His experience and expertise in over 300 clinical trials is pivotal in ensuring that clinical research continues to move in the right direction and properly represent the populations to which these medicines will be available.
A powerful and passionate speaker with a compelling story, Sheila Johnson is a pioneering breast cancer advocate with a particular focus on the black community. She has overcome personal adversity to help support and educate her community about the risks of breast cancer and how to advocate for yourself once diagnosed. “Breast cancer affects black women differently as we are proportionally dying at a faster rate due to many socioeconomic factors that affect the black community. All women should
be given the same standard of care and the same treatment options once diagnosed with breast cancer.”
Sheila uses her voice to raise awareness about the racial disparities faced by black women throughout their breast cancer journey. Receiving a breast cancer diagnosis is devastating for anyone, and Sheila passionately believes that racial disparities should not have an impact on the standard of treatment that black women receive. Sheila has also taken part in a clinical trial, something that she feels is vitally important because African American women are under-represented in clinical trials.
A metastatic breast cancer (MBC) survivor for 10 years, Sheila seeks to empower and support breast cancer patients and survivors, using her voice to educate and provide hope to other MBC patients.
Sheila is a decorated United States Air Force military veteran who served for 25 years active duty. She views every day as a chance to impact lives positively. “Every day is a new challenge for me. Every day, I get up and I ask myself how I can make the breast cancer community a better space not only for newly diagnosed women and men but also for survivors.”
Vice President, Commerical Strategy, Director of M.A.C.R.O.
Van Johnson, Vice President of Commercial Strategy is remarkably well known as one of the top five business development professionals within the industry. He is by far one of the most knowledgeable and sincere representatives of Benchmark’s ability to conduct clinical research trials. Significantly, Van is often a speaker at industry conferences and is a proud member of several URM (underrepresented minority) diversity committees including a committee member within STARR and Director of MACRO, Benchmark’s very own diversity committee.
EVP, Chief Customer Officer
Jackie comes to us with over 30 years of experience in IT and Clinical Development. She started her career in IT with Melvin Simon & Associates and then in 1990 moved to Eli Lilly, where she spent the last 27 years. At Lilly, Jackie started her career in IT within the infrastructure in very technical roles and progressed moving into more senior technical and leadership roles. In 2001, Jackie accepted a role in Clinical Development and that is where she continued building her leadership career.
Over the last 5 years, Jackie has represented Lilly on the TransCelerate OverSite Committee and also was the Sponsor & Leader of Shared Investigator Platform.
Jackie also was a member of the Society of Clinical Research Sites(SCRS) Leadership Council where she represented Pharma companies.
The last 3 years that Jackie spent at Lilly, she was the Sr. Director of Supply Planning and Systems. In this role she lead the team that was responsible for all of the clinical trial supply planning to the arrival and dispensing of drug to the patient. Jackie also have accountability for the IT systems that supported this teams, this included the Clinical Trial MRP system(SAP) and the Lilly IRT system.
One of the larger transformations both from a technical perspective and also business process was the co-development with Quintiles and Lilly of Infosario. Jackie led this with a co-leader from Quintiles. After Release 1.0 was complete, she took responsibility for the design and implementation of the organization to implement the new capabilities. This team was responsible for protocol optimization, feasibility, country selection and enrollment planning globally. This team grew in both capabilities and scope to eventually cover clinical planning through last patient entered treatment.
During Jackie’s time at Lilly she also gained OUS experience. She lived in both France and the UK from 1993 until 2008 when she returned to Indianapolis with her family.
Senior Analyst, Data Delivery
Lorena Kuri, MS
Head, Diversity Strategy
As the Head of Diversity Strategy at Bristol Myers Squibb, Lorena has been leading the diversity in clinical trials efforts for the past two years, with the objective of recruiting a patient population that reflect both the demographics of the real world and represent the epidemiology of the disease being studied. Prior to working at BMS, she spent several years in the Latin America and Canada Region in Novartis, where she started her career in Pharma back in Mexico over 15 years ago. As a strong inclusion advocate, she leverages her experience, intersectionality and personal purpose, as well as the roles she holds at the WOCIP Board of Directors, the RedShoeMovement Ambassador Program and her hometown Diversity Committee to build an inclusive culture that values differences and serves ALL populations. Lorena was awarded the 2020 PEOPLE EN ESPANOL MAGAZINE Recognition: “Las 25 Mujeres mas Influyentes” celebrating women who have made a difference empowering others.
Malia Lewin, JD
Global Head of Strategy
Malia Lewin is global head of strategy, ensuring both clinical and market fit for Teckro products. An attorney by training, Malia Lewin has over 20 years of experience in the life sciences industry. Passionate about getting life-changing healthcare innovations to patients, Malia has worked on behalf of non-profit organizations, pharmaceutical and biotechnology companies, hospital systems, and technology companies to expedite the path of scientific discoveries from bench to clinic.
Most recently, Malia served as chief business officer of CherryCircle Software, where she led the global go-to-market strategy for QbDVision, a SaaS platform to optimize the development and manufacturing of drug products. Prior to that, she served as director of global oncology strategy at Veeva Systems, where she worked closely with clients in the oncology space to harness the power of technology to develop and commercialize oncology innovations. During her seven-year tenure as VP of client services and head of strategic operations at Rivermark, LLC (an IQVIA company), Malia led strategic consulting teams advising on the development, launch, and adoption of diagnostics and treatments, across therapeutic areas. This included the development of novel digital products for stakeholder mapping and engagement, network visualization and activation, and reporting and analytics. Earlier in her career, Malia had the opportunity to serve non-profit organizations as the founding CEO and executive director of the International Psoriasis Council and as lead partner of Networking and Affiliations at Ascension Health.
Malia holds Bachelor of Arts Degrees in English and in Women’s Studies from the University of Richmond and a Juris Doctor from The George Washington University Law School.
Ana T. Marquez, MSF
Clinical Site Partners
Conduct Phase I-IV Respiratory, Sleep, Nephrology, Pediatric, CNS, Internal Medicine and Gastroenterology research. Our pulmonary research network has developed long term working relationships with our Sponsors and CRO’s because we have consistently met and exceeded enrollment goals. Often, CRO’s and sponsors recruit us to help them meet their enrollment goals, as well as to train or educate sites who are struggling with Asthma, COPD, bronchiectasis, OSA, or Narcolepsy subject enrollment. We are also proud members of hyperCORE International.
We have helped investigators establish or expand their research facilities, improve their quality control processes, trained sites on negotiating clinical trial agreements/budgets, implemented solid accounts receivables processes, assisted with FDA inspections, and Sponsor/IRB audits.
Professionally, I serve on SCRS’s Planning Committee. Formerly, I also served as Chairman for the Society for Clinical Research Sites’ (SCRS) Membership Committee, and on ACRP’s Committee for Investigative Sites.
Al Pacino II
BlueCloud® by HealthCarePoint
Mr. Pacino is a United States Army veteran and senior executive and with over 35 years in healthcare and clinical research. Actively involved as an innovator in the industry. As a 16-year cancer survivor with a passion to give back in making a difference in the industry, Mr. Pacino along with patients and patient survivors, co-founded the innovative BlueCloud® Network now saving healthcare and clinical research millions of dollars. Current Global Member base includes over 2 million healthcare professionals, 150 Sponsors, 45 CROs and over 200,000 healthcare and clinical research sites.
Amanda Rangel, MS, CCRC
Senior Vice President, Business Development
Total Diversity Clinical Trial Management
Amanda is well established and an expert in building relationships within the clinical trials industry. Her broad skill set covers business development, marketing, patient recruitment and operational roles within various organization types, including small sites, large global site networks, CROs, technology providers and startups.
Amanda has dedicated her career to improving the quality and efficiency of clinical trial conduct. Before Total Diversity, Amanda served as executive vice president of business development for VirTrial, a leading telehealth and decentralized clinical trial (DCT) platform provider designed specifically for clinical trials. Anticipating the need to support DCTs at the site level well in advance of COVID-19, VirTrial was thoughtfully positioned to support the continuity of clinical trial conduct throughout the pandemic. In her position, Amanda became a sought after DCT subject matter expert and speaker across the globe. VirTrial was ultimately acquired by Signant Health in 2020.
Prior to VirTrial, Amanda led the US-based global sales team for Synexus, the largest site network in the world with 200 sites across 11 countries. With centralized administrative processes and standardized business functions, the unique efficiencies of Synexus set it apart from other clinical research sites and ultimately led to its acquisition by PPD in 2015.
For the last decade, Amanda has been an active contributing member for the Society of Clinical Research Sites (SCRS), whose mission is to unify the voice of the global clinical research site community for site sustainability.
Amanda earned a Bachelor’s degree in Kinesiology from Arizona State University and a Master’s degree in Integrative Physiology from the University of Colorado at Boulder.
Fabian Sandoval, MD
CEO and Research Director
Emerson Clinical Research Institute
Dr. Fabian Sandoval, CEO & Research Director, has over 25 years of bench to bedside research experience. His diversified research career has been in academia, healthcare systems and the public sector. He received his Bachelors of Science in molecular and cellular biology from Marymount University, and his Doctorate of Medicine from the Autonomous University of Guadalajara, School of Medicine. He
Before opening the doors to Emerson Clinical Research Institute (ECRI) Dr. Sandoval’s research activities have included bench research at the National Institutes of Neurological Disorders and Stroke (NINDS) where he focused his work on Early Onset Alzheimer’s Disease, and Cretzfelt-Jakob Disease. At the NIHs’ Clinical Center conducting research in the outpatient Oncology unit, followed by his successful support of an NIH RO1 grant on preventing epilepsy in post-traumatic brain injury patients in adults and children, simultaneously run at the Washington Hospital Center, and Children’s National Medical Center.
Dr. Sandoval served as the Supervisory Research Integrity & Compliance Officer in the Army Human Research Protections Office in the Office of the Army Surgeon General. Responsibilities included establishment, and oversight of Human Research Protection Programs across Army commands. His input has been instrumental in the review, development, and selection of protocols, in addition to education and training for resident and hospital faculty.
Dr. Sandoval holds the following esteemed positions in the following community areas:
He has since started the Emerson Community Clinic, in order to support un-insured patients across the DC metro area, as well as starting the Emerson Diversity Health Foundation, who’s mission is to educate patients and providers in the importance of participating in clinical research and accesses to care.
VP, Site Growth and Adoption
Alicia Staley, MBA
VP, Patient Engagement
Alicia has over 20 years of experience in software design and information systems management. She has a Mechanical Engineering Degree from Syracuse University and from Boston University with a Masters of Information Systems and an MBA. At Medidata, Alicia works to infuse the patient perspective throughout the product development lifecycle and help engage patients in novel ways.
Alicia is also a three-time cancer survivor, first diagnosed with Hodgkin’s disease as a sophomore during college. Over the past 10 years, she’s applied her engineering background to improve the patient experience for those dealing with cancer. With an extensive network of patient advocates and non-profit organizations, she collaborates with a wide range of stakeholders to help improve processes and policies that impact cancer care.
An early adopter of social media, she co-founded #BCSM, which attracts over 1,000 global participants each week to its scheduled online discussions. Since its launch, #BCSM has been showcased at SXSW in 2013, 2014, 2015, and 2017 and is recognized as the gold standard for disease-specific social media networks. She’s co-led numerous research studies on how patients share information in online forums
As a champion of patient advocacy and engagement, she understands the critical issues facing patients seeking to engage in clinical research. With a keen focus on improving access to clinical trials, Alicia is passionate about making a difference for patients seeking clinical trials.
Eden Stein, MSc, PMP, CCRC
Executive Director, Patient Insights & Engagement of Centricity Research
LMC Manna Research
Dinorah Villanueva, MS, MBA
Associate Director, Diversity, Equity and Inclusion Process Lead
Dinorah Villanueva, MS, MBA, is Associate Director, Diversity, Equity and Inclusion Process Lead, Janssen Research & Development, LLC. In this role she works across Janssen’s therapeutic areas to develop and drive adoption of diversity, equity and inclusion processes and strategies aimed to increase participation of underrepresented and underserved populations in clinical trials. Dinorah has worked in clinical trials for more than 28 years. She joined Janssen in 1998 and has held various roles in global clinical trial planning, management, and coordination. She earned her MS degree from Florida State University and her MBA from Regis University.
David Vulcano, LCSW, MBA, CIP, RAC, ACRP-CP
David Vulcano brings nearly 30 years of experience within the clinical research industry and has been a member of the SCRS Leadership Council since 2015, providing guidance and direction for the company’s initiatives as a strong advocate for clinical research sites.
In addition to his new role with SCRS, Vulcano is chair of the SCRS Public Policy Committee and co-chair of SCRS’ Site Payment Initiative. He is a mentor to sites in the SCRS online site member community and frequent speaker at SCRS Site Solutions Summits, webinars, and Sites NOW meetings. Vulcano was selected as the recipient of the inaugural SCRS Christine K. Pierre Site Impact Award in 2019. Currently, Vulcano works with HCA Healthcare, where he has been Vice President of Research Compliance and Integrity for 14 years.